After enduring a two-year diagnostic odyssey, Gregory Maassen received a diagnosis of a postinfectious form of peripheral ...
As Gregory Maassen, Ph.D., prepares to e-bike more than 5,800 miles across the country, he's using the same sense of adventure and skills that he drew ...
(ENXTBR:ARGX) reported positive topline data from its Phase 3 ADAPT OCULUS trial of VYVGART in ocular myasthenia gravis. The ...
News Commentary - The global anti-aging therapy market is gaining serious momentum as people live longer and actively look ...
Fast Track designation reflects the unmet need in this serious disease and enables the potential for an accelerated FDA review timeline The designation is supported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results